Skip to main content Skip to main navigation menu Skip to the current issue Skip to site footer

Canadian Hematology Today

  • Home
  • Current
  • Archives
  • About
    • About the Journal
    • Editorial Board
    • Submissions
    • Journal Policies
  • Our Partners
  • Contact Us
  • Français
  • Login

Current Issue

Volume 2, Issue 1, March 2023
					View Volume 2, Issue 1, March 2023
Published: 2023-03-01

Articles

  • Frontline management of transplant-ineligible newly diagnosed multiple myeloma (TINDMM) in Canada

    Christopher Venner, MD, FRCPC, Julia Varghese, MD, FRCPC
    5–9
    • PDF (en)
    • PDF (fr)
  • Controversies and current practices in CNS relapse of diffuse large B-cell lymphoma

    Robert Puckrin, MD, FRCPC, Douglas A. Stewart, MD, FRCPC
    11–14
    • PDF (en)
    • PDF (fr)
  • Management of limited stage Hodgkin lymphoma

    Shruthi Kodad, DNB, FHO
    16–20
    • PDF (en)
    • PDF (fr)
  • Tyrosine kinase inhibitors for the frontline management of CML: an overview

    Dennis Dong Hwan Kim, MD, PhD
    22–26
    • PDF (en)
    • PDF (fr)
  • Venetoclax-based lower-intensity regimens for acute myeloid leukemia Clinical pearls for a new standard of care

    Guillaume Richard-Carpentier, MD, FRCPC
    28–33
    • PDF (en)
    • PDF (fr)
View All Issues
Recent Articles
  • Frontline management of transplant-ineligible newly diagnosed multiple myeloma (TINDMM) in Canada
  • Controversies and current practices in CNS relapse of diffuse large B-cell lymphoma
  • Management of limited stage Hodgkin lymphoma
  • Tyrosine kinase inhibitors for the frontline management of CML: an overview
  • Venetoclax-based lower-intensity regimens for acute myeloid leukemia Clinical pearls for a new standard of care

Summary

Journal title
Canadian Hematology Today.
Frequency
3 issues per year (March, June, October)
DOI Prefix
10.58931/cht

Make a Submission

Make a Submission

Open Access

Canadian Hematology Today is an open access journal, which means all its content is freely available without charge. Users are permitted to copy and redistribute the material in any medium or format for any noncommercial purpose, provided they cite the source.

License

© Canadian Hematology Today. Licensed under CC BY-NC-ND 4.0.

 

More information about the publishing system, Platform and Workflow by OJS/PKP.